Skip to content

Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Aphasia

Effects of a Combination of Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Non-fluent Aphasia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02226796
Enrollment
3
Registered
2014-08-27
Start date
2015-09-01
Completion date
2018-12-01
Last updated
2022-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia

Keywords

Broca's Aphasia, Transcranial Direct Current Stimulation

Brief summary

We hypothesize patients who have difficulty with word recall (naming pictures) due to a stroke will experience greater benefit in word recall after receiving a combination of transcranial direct current stimulation (tDCS) and traditional behavioral treatment. This study will investigate the effects of the timing of tDCS in relationship to the behavioral treatment to determine the most optimal protocol. Transcranial direct current stimulation involves placing two electrodes on your scalp and sending a very small electrical current to excite the brain cells of the target site.

Detailed description

Specific Aims Aim 1: Identify and quantify the effects of a-tDCS to the left dorsolateral prefrontal cortex (DLPFC) in conjunction with intensive behavioral treatment on naming in non-fluent aphasia. a-tDCS (2mA for 20 minutes) will be applied over the left DLPFC with cathode over the right orbit. Pre and post treatment behavioral measures of naming and working memory will be used to quantify and compare differences. Hypothesis 1: a-tDCS will result in improvements in naming accuracy, naming response times, and working memory (WM) in participants with non-fluent aphasia. Aim 2: Compare the effects of a-tDCS applied to the left DLPFC before behavioral treatment to during behavioral treatment in non-fluent aphasia. a-tDCS (2mA for 20 minutes) will be applied over the left DLPFC with cathode over the right orbit. Pre and post treatment behavioral measures of naming and working memory will be used to quantify and compare functional differences between conditions. Hypothesis 1: a-tDCS to the DLPFC during treatment will result in a greater improvement of naming accuracy, naming response time and WM in participants with non-fluent aphasia. Significance The findings from the proposed study will lay the foundation for a larger clinical trial which will in turn have a significant impact on individuals with aphasia given that naming deficits are a common symptom in this population. As the presence of naming deficits has a negative relationship to emotional well-being and functional communication 26-30, treatment that improves naming deficits will positively influence quality of life in many of these individuals. The approach taken to remediate naming deficits in aphasia is to treat impaired WM systems on the premise that certain cognitive processes underlie linguistic functions in aphasia. This approach represents a departure from most behavioral-based naming treatment approach, but reflects a growing recognition that WM systems in individuals with aphasia impact their linguistic performance 5, 31. The addition of a-tDCS as a neuromodulation tool to increase cortical excitability (upregulate) the working memory center to target naming is a novel approach. In addition, this study will further elucidate the optimal timing of a-tDCS in order to achieve the most beneficial outcomes, which have not yet been reported. These findings, along with other related studies, will shape future clinical practice guidelines as more studies adopt a concurrent cognitive-linguistic approach to treat linguistic deficits in aphasia. Design & Methodology Participants. Four individuals with aphasia will be recruited. These participants must meet the following inclusionary/exclusionary criteria: a) completion of high school or GED; b) normal or corrected-to-normal vision; c) adequate hearing acuity for 1:1 conversational exchanges; d) use of English as primary language; e) a vascular lesion in the dominant left hemisphere verified by an MRI scan within six months of the start of the study. These participants must also meet the following exclusionary criteria: a) no previous history of neurological- or psychiatric-based illnesses or disease, language or learning disabilities, or alcohol/substance abuse; b) no history of seizures; c) no metal implants in the head (except dental fillings); d) no lesion in the left DLPFC confirmed by MRI; e) no current pregnancy. Pre-Test Behavioral Measures. Participants will be seen between 2-3 sessions to undergo comprehensive cognitive-linguistic testing prior to initiation of treatment. Testing will take place at the University of Minnesota (UMN) Clinical Translational Science Institute (CTSI). Behavioral test measures will include the WAB 32 in order to obtain the WAB Aphasia Quotient (WAB AQ), Boston Naming Test (BNT) 33 and the Apraxia Battery for Adults (ABA-2) 34. The WAB AQ will provide a general classification of aphasia subtype, scores from the BNT will provide the level of severity of naming impairment, and ABA-2 performance will be used to assess severity of apraxia of speech (AoS). To assess the integrity of the phonological store, participants will be tested for the effects of phonological similarity using both auditory and visual presentation 35, 36. To assess the integrity of subvocal rehearsal processes, participants will be tested for the effects of word length on both auditory and visual span 37; the effects of articulatory suppression on recall performance 37, 38; and rhyme judgments 39-41. Protocols that have been adapted for individuals with aphasia will be followed42-45. These tests will be used to distinguish behavioral evidence of deficient subvocal rehearsal processes from deficient phonological short-term store. Individuals with a range of moderate to moderately severe nonfluent aphasia, a range of moderate to moderately severe anomia, and a range of mild to no AoS will be chosen for the study. Baseline probes will also be obtained prior to the initiation of the study. Stability of baseline performance, defined as no more than 20% difference between scores,will be obtained over three consecutive sessions in order to establish experimental control. Post-Test Behavioral Measures. Participants will also be seen for post-treatment testing following the implementation of the treatment protocol. Testing will take place in the participant's home. Post-treatment behavioral measures will include BNT, the ABA-2, WM tasks, and naming treatment and control items. It is anticipated that only one session will be needed for post-treatment testing. An adverse events survey will also be provided to assess the participant's level of discomfort during use of tDCS. tDCS Protocol. Each participant will be seated comfortably in a chair. A swim cap will be placed on the participant's head to identify cranial landmarks for accurate electrode placement. The area referred to as F3 by the International 10/20 system for electroencephalogram electrode placement46 has been established as the optimal location for targeting the left DLPFC25, 47-49. The F3 region will be located by marking the vertex (the midpoint between left and right tragus and midpoint between nasion and inion), measuring the head circumference. When these measurements are entered into the Beam F3 Locator Software50, additional values are provided to reliably identify the location of F3. Once F3 has been established, two saline soaked surface sponge electrodes (352cm) will be prepared and placed. For optimal anodal stimulation to the DLPFC, the anode will be placed over F3 and the cathode will be placed over the right supraorbital region23, 24, 47, 48. A current of 2mA will be delivered for 20 minutes 24 by a multichannel transcranial current stimulator (Starstim, Neuroelectrics Corporation; Cambridge, MA). a-tDCS will be applied before and during behavioral treatment in the design specified below. Treatment Design. Two treatment conditions will be presented in a counter-balanced order in a cross-over design. The non-prime (NONPRIME) condition will consist of 40 minutes of naming treatment only, followed by an additional 20 minutes of concurrent naming treatment with a-tDCS. The primed (PRIME) condition will consist of presentation of a-tDCS for 20 minutes prior to naming treatment, while the subject sits quietly and comfortably in a chair. After the 20-minute priming period, the a-tDCS will be removed and the participant will receive naming treatment for 60 minutes. Both conditions will be presented over four consecutive days. Two participants will receive NON-PRIME-PRIME sequence, with a one-month washout period between the two conditions. Two other participants will receive PRIME-NON-PRIME sequence, with a one-month washout period between the two conditions. Naming reaction time will be immediately evaluated after each treatment day.

Interventions

DEVICETranscranial direct current stimulation

Transcranial direct current stimulation (tDCS) is a non-invasive neuromodulation tool that presents a low current that induces bi-directional polarity-dependent changes in the cortex to facilitate focal, prolonged shifts in cortical excitability at or around the time stimulation is provided. Anodal tDCS (a-tDCS), in which the positively charged electrode is placed over the targeted cortical region, has been shown to increase cortical excitability (upregulation), similar to long-term potentiation (LTP). Combining a-tDCS with behavioral-based approaches has been suggested to enhance the learning process and increase the likelihood of retention.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* completion of high school or GED, normal or corrected-to-normal vision, adequate hearing acuity for 1:1 conversational exchanges, use of English as primary language, a vascular lesion in the dominant left hemisphere verified by an MRI scan within six months of the start of the study

Exclusion criteria

* no previous history of neurological- or psychiatric-based illnesses or disease, language or learning disabilities, or alcohol/substance abuse; no history of seizures; no metal implants in the head (except dental fillings); no lesion in the left DLPFC confirmed by MRI; no current pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Naming Reaction Time40 minutesParticipants are shown one or 3 possible banks of pictures balanced for phonemic complexity which are randomly assigned to prevent learning effect. Each bank contains 15 items. Time to recall is measured using a stop watch. The mean time to recall across all items is calculated and reported in milliseconds. The smaller the number, the faster / better the reaction time is.
Naming Accuracy40 minutesParticipants are shown one of 3 possible banks of pictures balanced for phonemic complexity which are randomly assigned to prevent learning effect. Each bank contains 15 items. Each trial is scored by an examiner as accurate (1) or inaccurate (0) based on articulatory accuracy of the participant's response. The average of all trials is calculated for each participant. Total scores range from 0-15 with higher scores indicating better naming accuracy/performance.

Secondary

MeasureTime frameDescription
Boston Naming Test30 minutesThe Boston Naming Test contains 60 line drawings of objects ranging from very common objects to less familiar. The examiner scores each item + or - according to scoring procedures. Total scores are calculated by adding up the number correct. Scores range from 0 to 60. Higher scores indicate greater ability to name objects.
Western Aphasia Battery Total Score60 minutesThe Western Aphasia Battery, a standardized assessment of language for individuals with aphasia, contains 32 short tasks. Each task has a separate scoring scheme yielding 8 sub-scores. Total score range from 0-100 with lower scores indicating greater aphasia severity. A score between 0-25 is very severe aphasia, 26-50 is severe aphasia, 51-75 is moderate aphasia, and 76-above is mild aphasia.
Working Memory Total Score2 monthsDuring the Working Memory battery, participants complete 12 auditory only or auditory & visual computer-based recall tasks. Twelve subset scores are calculated. Ten subtest ranges from 0-40 and 2 range from 0-60. Total score is calculated as sum of subtest scores and ranges from 0-520 with higher scores indicating greater working memory.

Countries

United States

Participant flow

Participants by arm

ArmCount
Sham Controlled tDCS Combined With Behavioral Naming Treatment
The primed (PRIME) condition is an intervention that will consist of presentation of a-tDCS for 20 minutes prior to 40 minutes of behavioral naming treatment, while the subject sits comfortably in a chair. The non-prime (NONPRIME) condition, sham/control is an intervention that will consist of 40 minutes of naming treatment only, followed by an additional 20 minutes of concurrent naming treatment with a-tDCS. Behavioral measures taken include: working memory, naming reaction time and naming accuracy
3
Total3

Baseline characteristics

CharacteristicSham Controlled tDCS Combined With Behavioral Naming Treatment
Age, Continuous58.33 years
STANDARD_DEVIATION 18.44
Boston Naming Test12 units on a scale
STANDARD_DEVIATION 0.81
Naming Accuracy4.48 units on a scale
STANDARD_DEVIATION 2.4
Naming Reaction Time2986.03 time in milliseconds
STANDARD_DEVIATION 1260.48
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
3 Participants
Region of Enrollment
United States
3 Participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
1 Participants
Western Aphasia Battery Score52.23 units on a scale
STANDARD_DEVIATION 12.3
Working Memory
AudioVisual_LongWordLength
16.33 units on a scale
STANDARD_DEVIATION 12.97
Working Memory
AudioVisual_ShortWordLength
17 units on a scale
STANDARD_DEVIATION 12.72
Working Memory
AudioVisual_WordSpan
18.66 units on a scale
STANDARD_DEVIATION 11.58
Working Memory
Total Score
148 units on a scale
STANDARD_DEVIATION 102.3
Working Memory
Visual_DigitSpan
8.66 units on a scale
STANDARD_DEVIATION 3.39
Working Memory
Visual_LongWordLength
6 units on a scale
STANDARD_DEVIATION 4.24
Working Memory
Visual_PhonologicallyDissimilarWords
12.5 units on a scale
STANDARD_DEVIATION 3.5
Working Memory
Visual_PhonologicallySimilarWords
7.66 units on a scale
STANDARD_DEVIATION 6.12
Working Memory
Visual_ShortWordLength
9.66 units on a scale
STANDARD_DEVIATION 5.79
Working Memory
Visual_WordSpan
11 units on a scale
STANDARD_DEVIATION 3.26

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 30 / 3
other
Total, other adverse events
0 / 30 / 3
serious
Total, serious adverse events
0 / 30 / 3

Outcome results

Primary

Naming Accuracy

Participants are shown one of 3 possible banks of pictures balanced for phonemic complexity which are randomly assigned to prevent learning effect. Each bank contains 15 items. Each trial is scored by an examiner as accurate (1) or inaccurate (0) based on articulatory accuracy of the participant's response. The average of all trials is calculated for each participant. Total scores range from 0-15 with higher scores indicating better naming accuracy/performance.

Time frame: 40 minutes

ArmMeasureValue (MEAN)Dispersion
Prime ConditionNaming Accuracy5.95 units on a scaleStandard Deviation 2.59
Non-Prime Condition/ControlNaming Accuracy6.044 units on a scaleStandard Deviation 2.32
Primary

Naming Reaction Time

Participants are shown one or 3 possible banks of pictures balanced for phonemic complexity which are randomly assigned to prevent learning effect. Each bank contains 15 items. Time to recall is measured using a stop watch. The mean time to recall across all items is calculated and reported in milliseconds. The smaller the number, the faster / better the reaction time is.

Time frame: 40 minutes

Population: This is a single subject cross over design where all three participants received both prime and non-prime condition

ArmMeasureValue (MEAN)Dispersion
Prime ConditionNaming Reaction Time1829.11 millisecondsStandard Deviation 643.4
Non-Prime Condition/ControlNaming Reaction Time3345.97 millisecondsStandard Deviation 1428.38
Secondary

Boston Naming Test

The Boston Naming Test contains 60 line drawings of objects ranging from very common objects to less familiar. The examiner scores each item + or - according to scoring procedures. Total scores are calculated by adding up the number correct. Scores range from 0 to 60. Higher scores indicate greater ability to name objects.

Time frame: 30 minutes

Population: The Co-PI collected data using the Boston Naming Test at baseline (before either prime or non-prime condition) and after both conditions were complete. No BNT data was collected between the two conditions, therefore we cannot determine the impact of the prime condition on BNT scores. Flawed execution of this outcome measure.

Secondary

Western Aphasia Battery Total Score

The Western Aphasia Battery, a standardized assessment of language for individuals with aphasia, contains 32 short tasks. Each task has a separate scoring scheme yielding 8 sub-scores. Total score range from 0-100 with lower scores indicating greater aphasia severity. A score between 0-25 is very severe aphasia, 26-50 is severe aphasia, 51-75 is moderate aphasia, and 76-above is mild aphasia.

Time frame: 60 minutes

Population: The Co-PI collected data using the Western Aphasia Battery at baseline (before either prime or non-prime condition) and after both conditions were complete. No BNT data was collected between the two conditions, therefore we cannot determine the impact of the prime condition on WAB scores. Flawed execution of this outcome measure.

Secondary

Working Memory Total Score

During the Working Memory battery, participants complete 12 auditory only or auditory & visual computer-based recall tasks. Twelve subset scores are calculated. Ten subtest ranges from 0-40 and 2 range from 0-60. Total score is calculated as sum of subtest scores and ranges from 0-520 with higher scores indicating greater working memory.

Time frame: 2 months

Population: The Co-PI collected data using the working memory assessment at baseline (before either prime or non-prime condition) and after both conditions were complete. No BNT data was collected between the two conditions, therefore we cannot determine the impact of the prime condition on working memory scores. Flawed execution of this outcome measure.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026